+1803294983432
customer.service@microbix.com
STI Antigen Materials
Common STI antigens driving superior detection for worldwide health concerns.
Setting the Gold Standard for Infectious Disease Diagnostic Standards
Decades of Diagnostics Excellence
For almost three decades, our infectious diseases antigens have been of the highest reliability and quality for diagnostic companies worldwide.
Superior Antigen Standards
Our antigen products are also excellent positive quality controls for diagnostics assays.
Tailored STI Antigen Products
Our STI antigen panel detects worldwide health concerns and is fit for any level of immunoassay you require.
Download Our Full Product Catalogue
Products
| Product Name | Catalogue Number | Description |
| Chlamydophila (Chlamydia) trachomatis, Grade 2 | EL-12-02 | Description: C. trachomatis grade 2 antigen contains a high concentration of elementary bodies and chlamydial components in PBS. The preparation contains no preservative or detergent. Residual host cellular material is present. Strain: C.trachomatis LGV type II strain 434. Buffer: Phosphate buffered saline pH 7.2
|
| Herpes Simplex 1, Grade 2 | EL-02-02 | Description: HSV-1 Grade 2 antigen contains a high concentration of virus particles and components in tissue culture medium containing a low concentration of bovine serum. The preparation contains no preservative or detergent. Some residual host cellular material is present. Strain: MacIntyre Buffer: Tissue culture medium
|
| Herpes Simplex 2, Grade 2 | EL-23-02 | Description: HSV-2 Grade 2 antigen contains a high concentration of virus particles and components in tissue culture medium containing a low concentration of bovine serum. The preparation contains no preservative or detergent. Some residual host cellular material is present. Strain: MS Buffer: Tissue culture medium
|
Frequently Asked Questions
What STIs are covered by your antigen materials and products, and do you offer a comprehensive panel of antigens for different infections?
Sexually transmitted infections covered by our STI antigen products include chlamydia trachomatis Grade 2, herpes simplex 1 Grade 2 and, herpes simplex 2, Grade 2.
Do you offer customizable options for antigen concentrations or formulations to meet specific assay needs?
Yes, for further information please contact customer service.
What quality control measures are in place while manufacturing your STI antigen products to ensure accuracy and consistency?
Our robust quality management system and our products are manufactured under ISO 9001:2015.
What is the shelf life of your STI antigen products?
Two years shelf life from shipping date.
Testimonials
Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions
Learn more about how our clients worldwide use Microbix’s product lines to enhance the way they do business.
We considered other external quality controls but selected Microbix QAPs as the best solution to support assay optimization and to significantly simplify QC procedures with minimal to no pipetting steps. Microbix’s technical expertise, product design, performance, and superior customer service are impressive. We look forward to continuing our collaboration.
Robert Martinez, VP of Business Development & Scientific Affairs
We were looking for a set of controls that fully covered the range of high-risk HPV types and Microbix is the only company to have such a portfolio. After an extensive evaluation process, we concluded the performance of Microbix QAPs are exactly what Ulisse needs and the interactions with their team are delightful.
Bruna Marini, COO
MDx testing for HPV improves cervical cancer screening by identifying those at-risk efficiently. Close monitoring of the entire HPV testing workflow is critical to realizing this healthcare goal and Microbix’s HPV QAPs have been selected to support the quality assessment monitoring of the molecular testing process, a vital part of BVO’s quality management system
Dr. Rob Schuurman, National Reference Officer for the Dutch Cervical Cancer Screening Program (BVO)
r-Biopharm is pleased that the program will be delivering world-class diagnostic testing to some of the most remote populations in Australia. It has been a privilege to work with the program’s operational team and Microbix to integrate the use of the best possible test and test-workflow controls into the program
Andreas Simons, Director, Project Management Clinical Diagnostics
We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program. Genital ulcers are the cause of a considerable and growing burden of disease that can only be alleviated by way of accurate diagnosis and treatment
Juha Wahlstedt, Sales Director at Labquality
Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™.
Gaetano Natale, Chief Commercial Officer.
We’ve been using Microbix’s External Quality controls for 3 years specifically from their Respiratory and Sexually Transmitted Infections panels on our instruments. It has helped us ensure accurate and reliable patient results and we’ve been delighted with their performance.
Alfie Zhen Fang, Buyer, Procurement
Your Dependable Source for STI Antigen Products
Microbix’s sexually transmitted diseases antigens products are purified and inactivated for infectivity, not antigenicity, to ensure utmost safety and satisfaction for STI testing end-users.
The STI antigens panel includes Chlamydia trachomatis grade 2, herpes simplex 1 grade 2 and, genital herpes simplex virus 2, grade 2.
Speak to an STI Antigen Customer Service Representative
Let our knowledgeable antigen experts help you secure your STI antigen controls supply today.
News & Insights from Our Diagnostics Experts
Microbix & API Ensuring Flu Tests Can Detect H5N1 Strain
announces its intentions to broaden its platform capabilities to enable production of a wider range of test ingredients (“Antigens”) by using recombinant production technologies....
Microbix Expanding Addressable Market Share with Test Makers
announces its intentions to broaden its platform capabilities to enable production of a wider range of test ingredients (“Antigens”) by using recombinant production technologies....
Microbix Reports Record Product Sales for Q4 and Fiscal 2024
reports results for its fiscal year and fourth quarter ended September 30, 2024 (“2024” and “Q4”) with record revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ...